As soon as regular trading closes at 4 PM Eastern Time, aftermarket movers kick-off. In this session, investors trade based on announcements of news such as earnings reports released before or just after the normal session ends. While a spike in trading volume may occur immediately after the news is released, it usually dwindles out by 6 PM.
This article presents 5 of the best aftermarket movers to invest in right now.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
COMSovereign Holding Corp. (COMS)
COMSovereign Holding Corp. (COMS) has advanced 53.85% at $0.068 in after-hours trading hours on the last check Monday. The stock of COMS gained 4.00% to complete the last trading session at $0.04. The price range of the company’s shares was between $0.0433 and $0.0468. It traded 5.67 million shares, which was above its daily average of 5.46 million shares over 100 days. COMS’s shares have dropped by -28.48% in the last five days, while they have subtracted -59.82% in the last month. Further, it is currently trading at a price-to-book ratio of 0.07.
Focusing on the company’s market volatility shows that it has a 1-Week Volatility index of 12.95%, and 15.38% for the month. This stock’s Average True Range (ATR) currently stands at 0.01, with the beta factor poised at 1.95. The indicator of Volatility helps exhibit the extent to which a stock is likely to plummet or climb when the rest of the market also dips or surges. If a stock has a beta score above 1, then its rate of volatility is high. Figures lower than 1, therefore, mean that the stock’s volatility at that particular moment is low.
Ra Medical Systems Inc. (RMED)
Ra Medical Systems Inc. (RMED) shares were rising 31.01% to trade at $7.14 in after-hours at the last check. RMED’s stock gained 10.77% to close Monday’s session at $5.45. The stock volume remained at 2.6 million shares, which was higher than the average daily volume of 0.5 million shares within the past 50 days. RMED shares have fallen by -96.43% over the last 12 months, and they have moved down by -15.37% in the past week. Over the past three months, the stock has lost -68.78%, while over the past six months, it has shed -67.37%. Further, the company has a current market of $5.99 million and its outstanding shares stood at 1.09 million.
With this outlook, analysts have a consensus recommendation rating of 1.50 for the stock, suggesting that investors Buy the stock. Piper Jaffray issued a stock update for Ra Medical Systems Inc. (RMED) on August 13, 2019, in which the firm assigned a “Neutral” rating. Maxim Group on November 02, 2018, rated the stock as “a Buy,”. 1 analyst offering their rating for the stock is split like this: 0 of the 1 rates it as a Hold; 1 sees it as a buy, while 0 says it is overweight. Although bullish, it is notable that the stock is well above its 200-day simple moving average by -73.33%, while it is -25.85% below and -13.38% below its SMA50 and SMA20 respectively. The volume of shares traded in the last session stands at 2.6 million against a 3-month average of 352.05K.
Advent Technologies Holdings Inc. (ADN)
Advent Technologies Holdings Inc. (ADN) shares have gained 19.90% at $2.47 in Monday’s after-hours session. Advent Technologies Holdings Inc.’s stock added 0.49% to finish the last trading session at $2.06. The stock recorded a trading volume of 0.68 million shares, which is below the average daily trading volume published for the last 50 days of 0.97 million shares. The shares of Advent Technologies Holdings Inc. have advanced -16.26% in the last five days; however, they have lost -43.56% over the last month. The stock price has shed -33.33% over the last three months and has lost -76.35 percent so far this year. Additionally, it has a price-to-sales ratio that stands at 13.65.
According to a U.S. Securities and Exchange Commission filing, BNP Paribas Funds – Energy Transi has reduced its position in Advent Technologies Holdings Inc. (ADN) to 7,264,216 shares, mirroring a recent drop by 0.00%. BNP Paribas Funds – Energy Transi dumped 0.0 shares of Advent Technologies Holdings Inc. common stock bringing its total worth to about $22.23 million at the end of a recent close, SEC documents show. BNP Paribas Funds – Energy Transi isn’t the only investment manager who changed stakes and is followed by Defiance Next Gen H2 ETF, which sold off 0.0 shares to end up with 744,572 shares worth $2.28 million. Vanguard Total Stock Market Index cut their holdings by -20.05% in the company over the course of the most recent quarter. It now holds a 1.40% position in Advent Technologies Holdings Inc. thanks to 0.72 million shares amounting to $2.22 million.
Statera Biopharma Inc. (STAB)
Statera Biopharma Inc. (STAB) is soaring on the charts today, down -11.46% to trade at $0.19 at last check in after-hours trading. On Monday, shares in Statera Biopharma Inc. rise 35.22% to close the day at $0.21. The volume of shares traded was 8.68 million, which is higher than the average volume over the last three months of 2.20 million. During the trading session, the stock oscillated between $0.151 and $0.2328. The company had an earnings-per-share ratio of -2.32. STAB’s stock has gained 25.42% of its value in the previous five sessions and 17.91% over the past month but has lost -90.67% on a year-to-date basis. The stock’s 50-day moving average of $0.1875 is above the 200-day moving average of $0.4996. Moreover, the stock is currently trading at an RSI of 60.67.
Volatility is just a proportion of the anticipated day-by-day value extension—the range where an informal investor works. Greater instability implies more noteworthy benefit or misfortune. After an ongoing check, Statera Biopharma Inc. (NASDAQ: STAB) stock is found to be 21.87% volatile for the week, while 21.34% volatility is recorded for the month. The outstanding shares have been calculated at 54.43M. Based on a recent bid, its distance from 20 days simple moving average is 39.41%, and its distance from 50 days simple moving average is 13.93% while it has a distance of -57.90% from the 200-day simple moving average.
Acorda Therapeutics Inc. (ACOR)
At last check in after-hours trading, shares of Acorda Therapeutics Inc. (ACOR) were down -8.25% at $0.823. ACOR’s stock closed the last session at $0.90, increasing 167.52% or $0.56. Shares of the company fluctuated between $0.4631 and $0.9369 throughout the day. The number of shares exchanged was 124.4 million, greater than the company’s 50-day daily volume of 2.94 million and higher than its Year-to-date volume of 1.34 million. In the past 12 months, the company’s stock has advanced by -80.96%, and in the last week, the stock has moved up 140.81%. For the last six months, the stock has lost a total of -40.60%, and over the last three months, the stock has increased by 80.19%. The stock has returned -62.47% so far this year.
COHEN RON, President and CEO, of Acorda Therapeutics Inc. (ACOR), sold 2,289 shares of Acorda Therapeutics Inc. stock in an exchange that took place on Mar 17. The shares were sold at an average price of 1.70 each, amounting to a total Sale worth $3,895. As of the close of the Sale, President and CEO now directly holds 129,601 shares of the organization’s stock, which is now worth about $116640.90. The deal was disclosed in a Securities & Exchange Commission legal filing, which can be publicly viewed on the SEC website.